You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 12, December 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psychopharmacology
 •Suicide
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

Antidepressants and the Risk of Suicide, Attempted Suicide, and Overall Mortality in a Nationwide Cohort

Jari Tiihonen, MD, PhD; Jouko Lönnqvist, MD, PhD; Kristian Wahlbeck, MD, PhD; Timo Klaukka, MD, PhD; Antti Tanskanen, PhLic; Jari Haukka, PhD

Arch Gen Psychiatry. 2006;63:1358-1367.

Background  It is unknown if antidepressant treatment is associated with either increased or decreased risk of suicide.

Objective  To estimate the risk of suicide, attempted suicide, and overall mortality during antidepressant treatments in a real-life setting with high statistical power.

Design and Setting  A cohort study in which all subjects without psychosis, hospitalized because of a suicide attempt from January 1, 1997, to December 31, 2003, in Finland, were followed up through a nationwide computerized database.

Participants  A total of 15 390 patients with a mean follow-up of 3.4 years.

Main Outcome Measures  The propensity score–adjusted relative risks (RRs) during monotherapy with the most frequently used antidepressants compared with no antidepressant treatment.

Results  In the entire cohort, fluoxetine use was associated with the lowest risk (RR, 0.52; 95% confidence interval [CI], 0.30-0.93), and venlafaxine hydrochloride use with the highest risk (RR, 1.61; 95% CI, 1.01-2.57), of suicide. A substantially lower mortality was observed during selective serotonin reuptake inhibitor use (RR, 0.59; 95% CI, 0.49-0.71; P<.001), and this was attributable to a decrease in cardiovascular- and cerebrovascular-related deaths (RR, 0.42; 95% CI, 0.24-0.71; P=.001). Among subjects who had ever used any antidepressant, the current use of medication was associated with a markedly increased risk of attempted suicide (39%, P<.001), but also with a markedly decreased risk of completed suicide (–32%, P=.002) and mortality (–49%, P<.001), when compared with no current use of medication. The results for subjects aged 10 to 19 years were basically the same as those in the total population, except for an increased risk of death with paroxetine hydrochloride use (RR, 5.44; 95% CI, 2.15-13.70; P<.001).

Conclusions  Among suicidal subjects who had ever used antidepressants, the current use of any antidepressant was associated with a markedly increased risk of attempted suicide and, at the same time, with a markedly decreased risk of completed suicide and death. Lower mortality was attributable to a decrease in cardiovascular- and cerebrovascular-related deaths during selective serotonin reuptake inhibitor use.


Author Affiliations: Department of Forensic Psychiatry, University of Kuopio and Niuvanniemi Hospital, and Department of Clinical Physiology, Kuopio University Hospital, Kuopio (Dr Tiihonen); Department of Psychiatry, University of Helsinki and Helsinki University Central Hospital (Drs Tiihonen and Lönnqvist), Department of Mental Health and Alcohol Research, National Public Health Institute (Drs Lönnqvist and Haukka and Mr Tanskanen), National Research and Development Centre for Welfare and Health (STAKES) (Dr Wahlbeck), and The Social Insurance Institution of Finland (Dr Klaukka), Helsinki; and Psychiatric Unit, Vaasa Central Hospital, Vaasa (Dr Wahlbeck), Finland.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Suicide in the Elderly: A Psychological Autopsy Study in a North Italy Area (1994-2004)
Pompili et al.
AJGP 2008;16:727-735.
ABSTRACT | FULL TEXT  

Determinants and Outcomes of Serious Attempted Suicide: A Nationwide Study in Finland, 1996-2003
Haukka et al.
Am J Epidemiol 2008;167:1155-1163.
ABSTRACT | FULL TEXT  

Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Morbidity and Mortality
Von Ruden et al.
J CARDIOVASC PHARMACOL THER 2008;13:32-40.
ABSTRACT  

Antidepressants increase risk of suicide attempt, but not completed suicide, in people with previous suicide attempts
Rihmer
Evid. Based Ment. Health 2007;10:90-90.
FULL TEXT  

Improving Detection of Adverse Effects of Marketed Drugs
Klein and O'Brien
JAMA 2007;298:333-334.
FULL TEXT  

Venlafaxine for major depression
Cipriani et al.
BMJ 2007;334:215-216.
FULL TEXT  

Do Antidepressants Make Patients Suicidal?
JWatch Psychiatry 2007;2007:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.